Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells

被引:89
作者
Wang, Y
Whittall, T
McGowan, E
Younson, J
Kelly, C
Bergmeier, LA
Singh, M
Lehner, T
机构
[1] Guys Kings & St Thomas Hosp, Sch Med, Mucosal Immunol Unit, Dept Oral Med & Pathol, London SE1 9RT, England
[2] Guys Kings & St Thomas Hosp, Sch Dent, Mucosal Immunol Unit, Dept Oral Med & Pathol, London SE1 9RT, England
[3] Guys Kings & St Thomas Hosp, Sch Dent, Mucosal Immunol Unit, Dept Oral Immunol, London SE1 9RT, England
[4] Guys Kings & St Thomas Hosp, Sch Med, Mucosal Immunol Unit, Dept Oral Immunol, London SE1 9RT, England
[5] Lionex Diagnost & Therapeut, Braunschweig, Germany
关键词
D O I
10.4049/jimmunol.174.6.3306
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The 70-kDa microbial heat shock protein (mHSP70) has a profound effect on the immune system, interacting with the CD40 receptor on DC and monocytes to produce cytokines and chemokines. The mHSP70 also induces maturation of dendritic cells (DC) and thus acts as an alternative ligand to CD40L on T cells. In this investigation, we have identified a cytokine-stimulating epitope (peptide 407-426), by activating DC with overlapping synthetic peptides (20-mers) derived from the sequence of mHSP70. This peptide also significantly enhances maturation of DC stimulated by mHSP70 or CD40L. The epitope is located at the base of the peptide-binding groove of HSP70 and has five critical residues. Furthermore, an inhibitory epitope (p457-496) was identified downstream from the peptide-binding groove that inhibits cytokine production and maturation of DC stimulated by HSP70 or CD40L. The p38 MAP kinase phosphorylation is critical in the alternative CD40-HSP70 pathway and is inhibited by p457-496 but enhanced by p407-426.
引用
收藏
页码:3306 / 3316
页数:11
相关论文
共 51 条
[1]  
Aicher A, 1999, J IMMUNOL, V163, P5786
[2]   HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine [J].
Asea, A ;
Kraeft, SK ;
Kurt-Jones, EA ;
Stevenson, MA ;
Chen, LB ;
Finberg, RW ;
Koo, GC ;
Calderwood, SK .
NATURE MEDICINE, 2000, 6 (04) :435-442
[3]   MYCOBACTERIAL HEAT-SHOCK PROTEINS AS CARRIER MOLECULES .2. THE USE OF THE 70-KDA MYCOBACTERIAL HEAT-SHOCK PROTEIN AS CARRIER FOR CONJUGATED VACCINES CAN CIRCUMVENT THE NEED FOR ADJUVANTS AND BACILLUS-CALMETTE-GUERIN PRIMING [J].
BARRIOS, C ;
LUSSOW, AR ;
VANEMBDEN, J ;
VANDERZEE, R ;
RAPPUOLI, R ;
COSTANTINO, P ;
LOUIS, JA ;
LAMBERT, PH ;
DELGIUDICE, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (06) :1365-1372
[4]  
Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO
[5]  
2-C
[6]   CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes [J].
Becker, T ;
Hartl, FU ;
Wieland, F .
JOURNAL OF CELL BIOLOGY, 2002, 158 (07) :1277-1285
[7]   A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection [J].
Bogers, WMJM ;
Bergmeier, LA ;
Ma, J ;
Oostermeijer, H ;
Wang, YF ;
Kelly, CG ;
ten Haaft, P ;
Singh, M ;
Heeney, JL ;
Lehner, T .
AIDS, 2004, 18 (01) :25-36
[8]   Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways [J].
Castellino, F ;
Boucher, PE ;
Eichelberg, K ;
Mayhew, M ;
Rothman, JE ;
Houghton, AN ;
Germain, RN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1957-1964
[9]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[10]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752